Identification of potent small molecule inhibitors of SARS-CoV-2 entry

The severe acute respiratory syndrome coronavirus 2 responsible for COVID-19 remains a persistent threat to mankind, especially for the immunocompromised and elderly for which the vaccine may have limited effectiveness. Entry of SARS-CoV-2 requires a high affinity interaction of the viral spike prot...

Descripción completa

Detalles Bibliográficos
Autores principales: Mediouni, Sonia, Mou, Huihui, Otsuka, Yuka, Jablonski, Joseph Anthony, Adcock, Robert Scott, Batra, Lalit, Chung, Dong-Hoon, Rood, Christopher, de Vera, Ian Mitchelle S., Rahaim Jr., Ronald, Ullah, Sultan, Yu, Xuerong, Getmanenko, Yulia A., Kennedy, Nicole M., Wang, Chao, Nguyen, Tu-Trinh, Hull, Mitchell, Chen, Emily, Bannister, Thomas D., Baillargeon, Pierre, Scampavia, Louis, Farzan, Michael, Valente, Susana T., Spicer, Timothy P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Inc. on behalf of Society for Laboratory Automation and Screening. 2022
Materias:
Full Length Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8577999/
https://www.ncbi.nlm.nih.gov/pubmed/35058179
http://dx.doi.org/10.1016/j.slasd.2021.10.012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8577999/
https://www.ncbi.nlm.nih.gov/pubmed/35058179
http://dx.doi.org/10.1016/j.slasd.2021.10.012

Ejemplares similares